[Indications and medical therapy of hypoglycemic beta-insular].
D007516:Adenoma, Islet Cell / Q000188:drug therapy*; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D003981:Diazoxide / Q000009:adverse effects / Q000627:therapeutic use*; D004232:Diuretics; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia; D008466:Mechlorethamine / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D013311:Streptozocin / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D008466:Mechlorethamine; D013311:Streptozocin; D005934:Glucagon; D003981:Diazoxide; D005472:Fluorouracil
Indicazioni e terapia medica dei tumori beta-insulari ipoglicemizzanti.